Controlled Study of Post-transplant Azacitidine for Prevention of Acute Myelogenous Leukemia and Myelodysplastic Syndrome Relapse (VZ-AML-PI-0129)

Name: Controlled Study of Post-transplant Azacitidine for Prevention of Acute Myelogenous Leukemia and Myelodysplastic Syndrome Relapse (VZ-AML-PI-0129)
Published: 2009
License: Public Domain

M.D. Anderson Cancer Center · 2009

ClinicalTrials.gov · Datasets · License: Public Domain · 2009

Open Source ↗

leukemia remission

leukemia, aml, mds, acute myelogenous leukemia, myelodysplastic syndrome, remission, allogeneic stem cell transplant, allotx, azacitidine, 5-azacitidine, 5-aza, vidaza

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 854341
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.